The Coming Psychedelic Boom
Warning to all investors: There's a coming boom that might make the CBD craze look like an outdated investment.

NYSE:BG - Bunge Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $85.00
  • Forecasted Upside: 6.56 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$79.77
▼ -0.41 (-0.51%)

This chart shows the closing price for BG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Bunge Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BG

Analyst Price Target is $85.00
▲ +6.56% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Bunge in the last 3 months. The average price target is $85.00, with a high forecast of $100.00 and a low forecast of $61.00. The average price target represents a 6.56% upside from the last price of $79.77.

This chart shows the closing price for BG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
Seattle Cannabis Blockbuster Set to Double Sales in Next 2 Years!
Thanks to a recent reorganization, acquisitions, and strategic partnerships, one Seattle cannabis blockbuster is poised for a massive expansion in the coming 24 months. With plans to double its annual sales in the next two years, this company’s shares could potentially skyrocket in value.

Current Consensus is Buy

The current consensus among 6 contributing investment analysts is to buy stock in Bunge. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 1 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/30/2019
  • 1 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/29/2020
  • 1 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/27/2020
  • 1 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/25/2020
  • 1 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/24/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/24/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/23/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/22/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/10/2021Morgan StanleyBoost Price TargetEqual Weight$72.00 ➝ $92.00Low
5/6/2021BarclaysBoost Price TargetPositive ➝ Overweight$85.00 ➝ $100.00Low
5/5/2021Credit Suisse GroupBoost Price TargetOutperform$84.00 ➝ $95.00High
4/21/2021Bank of AmericaInitiated CoverageNeutral$88.00Medium
2/11/2021Credit Suisse GroupBoost Price TargetPositive ➝ Outperform$72.00 ➝ $84.00Low
2/11/2021BarclaysBoost Price TargetOverweight$70.00 ➝ $85.00Low
12/21/2020BarclaysBoost Price TargetPositive ➝ Overweight$65.00 ➝ $70.00Low
12/14/2020Morgan StanleyBoost Price TargetEqual Weight$66.00 ➝ $72.00Medium
12/10/2020Credit Suisse GroupBoost Price TargetOutperform$67.00 ➝ $72.00High
10/29/2020Credit Suisse GroupBoost Price TargetOutperform$60.00 ➝ $67.00Low
10/29/2020Morgan StanleyBoost Price TargetEqual Weight$50.00 ➝ $66.00Low
10/19/2020JPMorgan Chase & Co.Boost Price TargetNeutral$47.00 ➝ $61.00Medium
8/14/2020Credit Suisse GroupBoost Price TargetPositive ➝ Outperform$50.00 ➝ $53.00Medium
7/27/2020Credit Suisse GroupLower Price Target$65.00 ➝ $50.00Low
6/25/2020StephensReiterated RatingBuy$74.00High
6/25/2020Credit Suisse GroupReiterated RatingBuy$65.00High
5/13/2020Robert W. BairdUpgradeNeutral ➝ Outperform$46.00Low
3/31/2020Robert W. BairdBoost Price TargetNeutral$39.00 ➝ $46.00High
3/30/2020Morgan StanleyLower Price TargetEqual Weight$65.00 ➝ $50.00High
3/17/2020The Goldman Sachs GroupUpgradeBuy ➝ Conviction-Buy$69.00High
12/10/2019The Goldman Sachs GroupUpgradeNeutral ➝ Buy$64.00 ➝ $67.00High
11/4/2019Credit Suisse GroupReiterated RatingBuyLow
10/8/2019StephensInitiated CoverageOverweight$74.00High
3/28/2019JPMorgan Chase & Co.Initiated CoverageNeutral$67.00Low
2/25/2019Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$84.00 ➝ $65.00Low
2/22/2019BMO Capital MarketsReiterated RatingOutperformHigh
1/23/2019Credit Suisse GroupSet Price TargetOutperform$77.00 ➝ $70.00Medium
1/15/2019Credit Suisse GroupReiterated RatingOutperform$77.00High
12/10/2018CitigroupLower Price TargetBuy ➝ Buy$82.00 ➝ $80.00Medium
11/1/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$87.00 ➝ $83.00Low
11/1/2018CitigroupLower Price TargetBuy ➝ Buy$92.00 ➝ $82.00Low
8/2/2018CitigroupLower Price TargetBuy ➝ Buy$100.00 ➝ $92.00Medium
8/2/2018Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$80.00 ➝ $77.00Medium
8/2/2018JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$82.00 ➝ $75.00Medium
7/9/2018JPMorgan Chase & Co.UpgradeBuy$82.00Low
5/3/2018Credit Suisse GroupLower Price TargetOutperform ➝ Buy$84.00 ➝ $80.00Medium
5/3/2018CitigroupBoost Price TargetBuy$100.00High
3/7/2018JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$90.00Low
3/6/2018CitigroupUpgradeNeutral ➝ Buy$77.99 ➝ $89.00High
2/16/2018Credit Suisse GroupReiterated RatingBuy$84.00Medium
2/15/2018Piper Jaffray CompaniesReiterated RatingBuyMedium
2/15/2018StephensUpgradeEqual Weight ➝ OverweightMedium
1/22/2018Credit Suisse GroupSet Price TargetBuy$84.00Low
12/14/2017Vertical ResearchUpgradeHold ➝ BuyLow
11/6/2017BMO Capital MarketsReiterated RatingBuy$87.00N/A
10/13/2017Robert W. BairdReiterated RatingHold$77.00N/A
10/6/2017Piper Jaffray CompaniesSet Price TargetBuy$86.00N/A
9/28/2017CitigroupDowngradeBuy ➝ Neutral$75.00High
9/15/2017Credit Suisse GroupReiterated RatingBuy$90.00Low
9/12/2017Vertical ResearchDowngradeBuy ➝ HoldLow
9/11/2017Robert W. BairdInitiated CoverageNeutral$77.00High
9/5/2017Piper Jaffray CompaniesReiterated RatingBuy$86.00Low
8/3/2017Piper Jaffray CompaniesSet Price TargetBuy$86.00Medium
7/21/2017Piper Jaffray CompaniesReiterated RatingBuy$84.00Low
7/18/2017Credit Suisse GroupSet Price TargetBuy$90.00High
7/14/2017Piper Jaffray CompaniesSet Price TargetBuy$79.00Low
7/12/2017CitigroupLower Price TargetBuy$94.00 ➝ $88.00Low
7/4/2017JPMorgan Chase & Co.DowngradeNeutral - Underweight$70.00N/A
6/12/2017BMO Capital MarketsSet Price TargetBuy$87.00Low
6/9/2017Credit Suisse GroupBoost Price TargetOutperform$80.00 ➝ $90.00High
5/25/2017Credit Suisse GroupReiterated RatingHold$80.00Low
5/15/2017BMO Capital MarketsReiterated RatingBuyN/A
5/5/2017BMO Capital MarketsReiterated RatingBuyLow
5/4/2017Credit Suisse GroupSet Price TargetBuy$80.00Low
5/4/2017JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$70.00High
5/3/2017StephensDowngradeOverweight ➝ Equal WeightHigh
4/6/2017JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$70.00Low
3/20/2017The Goldman Sachs GroupDowngradeBuy ➝ Neutral$88.00High
2/27/2017Credit Suisse GroupSet Price TargetBuy$85.00N/A
12/14/2016Piper Jaffray CompaniesSet Price TargetBuy$82.00N/A
8/2/2016Bank of AmericaUpgradeNeutral ➝ BuyN/A
8/1/2016BMO Capital MarketsReiterated RatingOutperform$72.00N/A
7/12/2016Truist FinancialInitiated CoverageBuy$75.00N/A
(Data available from 6/23/2016 forward)
Bunge logo
Bunge Limited operates as an agribusiness and food company worldwide. It operates through five segments: Agribusiness, Edible Oil Products, Milling Products, Fertilizer, and Sugar and Bioenergy. The Agribusiness segment purchases, stores, transports, processes, and sells agricultural commodities and commodity products, including oilseeds primarily soybeans, rapeseed, canola, and sunflower seeds, as well as grains primarily wheat and corn; and vegetable oils and protein meals. It provides its products for animal feed manufacturers, livestock producers, wheat and corn millers, and other oilseed processors, as well as third-party edible oil processing companies; and for industrial and biodiesel production applications. The Edible Oil Products segment provides packaged and bulk oils and fats, including cooking oils, shortenings, margarines, mayonnaise, and others for baked goods companies, snack food producers, confectioners, restaurant chains, foodservice operators, infant nutrition companies, and other food manufacturers, as well as grocery chains, wholesalers, distributors, and other retailers. The Milling Products segment offers wheat flours and bakery mixes; corn milling products that include dry-milled corn meals and flours, wet-milled masa and flours, and flaking and brewer's grits, as well as soy-fortified corn meal, corn-soy blends, and other products; and whole grain and fiber ingredients. The Fertilizer segment offers nitrogen, phosphate, and potassium fertilizers; and SSP, ammonia, ammonium thiosulfate, monoammonium phosphate, diammonium phosphate, triple superphosphate, urea, urea-ammonium nitrate, ammonium sulfate, and potassium chloride. The Sugar and Bioenergy segment produces sugar and ethanol; and generates electricity from burning sugarcane bagasse. The company was founded in 1818 and is headquartered in St. Louis, Missouri.
Read More

Today's Range

Now: $79.77
Low: $78.63
High: $80.64

50 Day Range

MA: $85.94
Low: $77.20
High: $91.32

52 Week Range

Now: $79.77
Low: $38.00
High: $92.38

Volume

1,530,295 shs

Average Volume

1,384,743 shs

Market Capitalization

$11.28 billion

P/E Ratio

5.47

Dividend Yield

2.49%

Beta

0.69

Frequently Asked Questions

What sell-side analysts currently cover shares of Bunge?

The following Wall Street analysts have issued stock ratings on Bunge in the last twelve months: Bank of America Co., Barclays PLC, Credit Suisse Group AG, JPMorgan Chase & Co., Morgan Stanley, Stephens, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for BG.

What is the current price target for Bunge?

6 Wall Street analysts have set twelve-month price targets for Bunge in the last year. Their average twelve-month price target is $85.00, suggesting a possible upside of 6.3%. Barclays PLC has the highest price target set, predicting BG will reach $100.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $61.00 for Bunge in the next year.
View the latest price targets for BG.

What is the current consensus analyst rating for Bunge?

Bunge currently has 3 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BG will outperform the market and that investors should add to their positions of Bunge.
View the latest ratings for BG.

What other companies compete with Bunge?

Other companies that are similar to Bunge include Archer-Daniels-Midland, Darling Ingredients, Ingredion, Fresh Del Monte Produce, Limoneira and Alico.

How do I contact Bunge's investor relations team?

Bunge's physical mailing address is 1391 TIMBERLAKE MANOR PARKWAY, ST. LOUIS MO, 63017. The basic materials company's listed phone number is 314-292-2000 and its investor relations email address is [email protected] The official website for Bunge is www.bunge.com.

Seattle Cannabis Blockbuster Set to Double Sales in Next 2 Years!
Thanks to a recent reorganization, acquisitions, and strategic partnerships, one Seattle cannabis blockbuster is poised for a massive expansion in the coming 24 months. With plans to double its annual sales in the next two years, this company’s shares could potentially skyrocket in value.